Cessation Therapeutics, a biotechnology company that focuses on developing treatments for substance abuse, has received a new grant from the National Institute on Drug Abuse (NIDA) to support fentanyl overdose treatment.
Read More
The Food and Drug Administration has authorized Chapel Hill-based Cessation Therapeutics to begin a clinical trial on a monoclonal antibody is designed to prevent fentanyl overdoses. Here are the details.
Read More
The first-ever point-of-care instrument for qualitatively detecting fentanyl in human urine has been cleared for use by the U.S. Food Drug Administration and will be distributed in the United States by a Greensboro-based company.
Read More
A controversial tool has emerged in the fight against opioid overdose deaths. It’s a strip that allows people who use street drugs such as cocaine and heroin to test whether their drugs are laced with fentanyl.
Read More
